News - ARCH Venture Partners
September 26, 2024 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces New Fund to Create the Next Generation of Biotech Companies April 23, 2024 Media Coverage from ARCH Venture Partners | Share With ARCH funding, Xaira Therapeutics aims to reinvent drug R&D by using artificial intelligence to deliver ...
ARCH Venture Partners Announces New Fund to Create the Next …
CHICAGO, September 26, 2024 – ARCH Venture Partners today announced the closing of ARCH Venture Fund XIII, a venture capital fund with more than $3 billion to support the founding and growth of early-stage biotechnology companies.
ARCH Venture Partners Announces New Fund to Create the Next …
CHICAGO, Sept. 26, 2024 /PRNewswire/ -- ARCH Venture Partners today announced the closing of ARCH Venture Fund XIII, a venture capital fund with more than $3 billion to support the...
arch venture partners News & Press Releases | PR Newswire
Dec 8, 2022 · ARCH Venture Partners today announced the closing of ARCH Venture Fund XII, with $2.975 billion to invest in the creation, development and funding of ... ARCH Venture Partners today...
ARCH Venture Partners Announces $1.46 Billion Raised in Two …
Apr 2, 2020 · ARCH Venture Partners today announced the closing of two new funds, ARCH Venture Fund X and ARCH Venture Fund X Overage, with a combined $1.46 billion to invest in transformative, early stage biotechnology companies.
Arch raises another $3B biotech fund in pursuit of ‘coolest’ new ...
Sep 26, 2024 · Arch Venture Partners, a prominent creator of biotechnology startups, has raised more than $3 billion for its 13th fund, the firm announced Thursday. The fundraise comes only two years after Arch secured a similar-sized haul that, at the time, was its largest to date.
Arch, a prolific biotech creator, is raising $3B for startup investing
Feb 2, 2024 · Arch Venture Partners, one of the biotechnology sector’s most prolific company creators, is raising a new $3 billion fund, according to a regulatory filing. The fund, which would be Arch’s 13th, is being put together less than two years after the firm closed a similar-sized $3 billion raise that was its largest to date.
Arch closes $3B-plus fund to foster biopharma upstarts
Sep 26, 2024 · | Arch Venture Partners announced the closing of its 13th venture fund, which is infused with more than $3 billion to support the founding and buildup of early-stage biotech companies.
ARCH Venture Partners raises $3 billion for a new biotech fund
Sep 26, 2024 · ARCH Venture Partners has raised $3 billion for a new fund — one of the largest in the biotech industry, and one the VC firm will use to continue its contrarian investment strategy.
ARCH Fuels Up With $3B to Support Next Class of AI Biotechs
Sep 26, 2024 · ARCH Venture Partners has topped up its coffers with a whopping $3 billion fund, which will be used to fuel the next generation of AI-focused biotechs. The venture capital firm announced the closing of the ARCH Venture Fund XIII on Thursday, pledging to back companies working with AI and data-driven insights into biology.